Amy Gravell
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- CAR-T cell therapy research
-
- Cancer Genomics and Diagnostics
Papers in
-
- Genetics, Bioinformatics, and Biomedical Research 1
- Histone Deacetylase Inhibitors Research 1
- Oncology 3
- Cancer Treatment and Pharmacology 1
- Co-authors
- Susan Groshen (2 shared papers)Mark J. Ratain (2 shared papers)Ralph E. Parchment (1 shared paper)Lawrence D. True (1 shared paper)J. Milburn Jessup (1 shared paper)Lalitha Shankar (1 shared paper)Walter M. Stadler (1 shared paper)Janet Dancey (1 shared paper)
- Journals
- Clinical Cancer Research (3 papers)JNCI Cancer Spectrum (1 paper)Frontiers in Medicine (1 paper)PubMed (3 papers)
- Partner nations
- United StatesCanada
In The Last Decade
Amy Gravell
10 papers receiving 293 citations
Peers
Comparison fields: 5 of 56
- Oncology 151
- Cancer Research 82
- Statistics and Probability 39
- Pulmonary and Respiratory Medicine 66
- Neurology 29
Countries citing papers authored by Amy Gravell
This map shows the geographic impact of Amy Gravell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Gravell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Gravell more than expected).
Fields of papers citing papers by Amy Gravell
This network shows the impact of papers produced by Amy Gravell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Gravell. The network helps show where Amy Gravell may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy Gravell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 173 | |
| 2 | 2018 | 89 | |
| 3 | 2019 | 10 | |
| 4 | Clinical trials referral resource. Current clinical trials of BAY 43-9006, Part 1. | 2005 | 8 |
| 5 | Clinical trials referral resource. Current clinical trials of R115777 (Zarnestra). | 2002 | 7 |
| 6 | 2019 | 6 | |
| 7 | Clinical trials referral resource. Flavopiridol. | 2002 | 5 |
| 8 | 2015 | 2 | |
| 9 | Current Clinical Trials of Flavopiridol | 2002 | 1 |
| 10 | Current Clinical Trials of Fenretinide | 2001 | 1 |
About Amy Gravell
Amy Gravell is a scholar working on Molecular Biology, Oncology, Statistics and Probability, Cancer Research and Biomedical Engineering, having authored 10 papers that have together received 302 indexed citations. Recurring topics across this work include Statistical Methods in Clinical Trials (3 papers), Cancer Genomics and Diagnostics (2 papers), Synthetic Organic Chemistry Methods (1 paper), Cancer Treatment and Pharmacology (1 paper), Genetics, Bioinformatics, and Biomedical Research (1 paper), Histone Deacetylase Inhibitors Research (1 paper), Health Systems, Economic Evaluations, Quality of Life (1 paper) and Health and Medical Research Impacts (1 paper). The work is most often cited by research in Oncology (151 citations), Cancer Research (82 citations), Statistics and Probability (39 citations), Pulmonary and Respiratory Medicine (66 citations) and Neurology (29 citations). Amy Gravell has collaborated with scholars based in United States and Canada. Frequent co-authors include Susan Groshen, Mark J. Ratain, Ralph E. Parchment, Lawrence D. True, J. Milburn Jessup, Lalitha Shankar, Walter M. Stadler, Janet Dancey, María Koehler and Michael R. Grever. Their work appears in journals such as Clinical Cancer Research, JNCI Cancer Spectrum, Frontiers in Medicine and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.